Zobrazeno 1 - 10
of 13
pro vyhledávání: '"van Ineveld Rl"'
Autor:
van Vliet Ej, Hans Clevers, Wehrens Ej, Alieva M, Oded Kopper, Rebel Hg, Kai Kretzschmar, A. D. Meringa, Rios Ac, Yotam E. Bar-Ephraim, van Ineveld Rl, Peter Brazda, Domenico Fasci, Ariese Hc, Farid Keramati, Inez Johanna, Buchholz M, Henk Stunnenberg, Johanna F. Dekkers, J. Kuball, Karaiskaki E, Eggermont Am, Zsolt Sebestyén, Wezenaar Ak, Maarten H. Geurts, Román Mb, Jens Puschhof, Cleven A
SummaryCellular immunotherapies are rapidly gaining clinical importance, yet predictive platforms for modeling their mode of action are lacking. Here, we developed a dynamic immuno-organoid 3D imaging-transcriptomics platform; BEHAV3D, to unravel the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3449ee2bfa7051e711bd3325bf3838
https://doi.org/10.1101/2021.05.05.442764
https://doi.org/10.1101/2021.05.05.442764
Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes.
Autor:
de Kanter JK; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Steemers AS; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Gonzalez DM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Blijleven C; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: University of Copenhagen Copenhagen Denmark., Groenen N; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Trabut L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Westera L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Beishuizen A; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Brandsma AM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: Sanquin Blood Bank Amsterdam the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., van Boxtel R; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Meyer-Wentrup F; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2024 Sep 02; Vol. 8 (9), pp. e149. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).
Autor:
Jeremiasse B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Bok V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Instituto de Investigaciones Biomedicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wellens LM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Llibre-Palomar G; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Di Maggio A; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Oliveira S; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Steeg AF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Jul; Vol. 16 (7), pp. 1495-1514. Date of Electronic Publication: 2024 Jun 03.
Autor:
Dekkers JF; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Cleven A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Keramati F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Wezenaar AKL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Puschhof J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Microbiome and Cancer Division, German Cancer Research Center, Heidelberg, Germany., Brazda P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Johanna I; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Meringa AD; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rebel HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Buchholz MB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Fasci D; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Geurts MH; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Driehuis E; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Millen R; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Straetemans T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Nicolasen MJT; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Aarts-Riemens T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ariese HCR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Karaiskaki F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Kopper O; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Bar-Ephraim YE; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Kretzschmar K; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Mildred Scheel Early Career Center for Cancer Research Würzburg, University Hospital Würzburg, MSNZ/IZKF, Wurzburg, Germany., Eggermont AMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.; Comprehensive Cancer Center München, Munich, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Pharma, Research and Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyen Z; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2023 Jan; Vol. 41 (1), pp. 60-69. Date of Electronic Publication: 2022 Jul 25.
Autor:
van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Collot R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Román MB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Pagliaro A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Bessler N; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Ariese HCR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center DKFZ and German Cancer Consortium DKTK, Heidelberg, Germany., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Chuva de Sousa Lopes SM; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature protocols [Nat Protoc] 2022 Dec; Vol. 17 (12), pp. 3028-3055. Date of Electronic Publication: 2022 Sep 30.
Autor:
Wang Z; Woo Center for Big Data and Precision Health, Pratt School of Engineering, Duke University, Durham, NC, USA., Boretto M; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Millen R; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Natesh N; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., Reckzeh ES; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Hsu C; College of Arts and Sciences, University of Chapel Hill, Chapel Hill, NC, USA., Negrete M; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., Yao H; Biology Department, Trinity School of Arts and Sciences, Duke University, Durham, NC, USA., Quayle W; Xilis, Inc., Durham, NC, USA., Heaton BE; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA., Harding AT; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA., Bose S; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., Driehuis E; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Beumer J; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Rivera GO; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 Utrecht, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 Utrecht, the Netherlands., Gex D; Xilis, Inc., Durham, NC, USA., DeVilla J; Xilis, Inc., Durham, NC, USA., Wang D; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Puschhof J; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Microbiome and Cancer Division, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Geurts MH; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands., Yeung A; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., Hamele C; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA., Smith A; Xilis, Inc., Durham, NC, USA., Bankaitis E; Xilis, Inc., Durham, NC, USA., Xiang K; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA., Ding S; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA; Xilis, Inc., Durham, NC, USA., Nelson D; Xilis, Inc., Durham, NC, USA., Delubac D; Xilis, Inc., Durham, NC, USA., Rios A; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 Utrecht, the Netherlands., Abi-Hachem R; Department of Head and Neck Surgery and Communication Sciences, School of Medicine, Duke University, Durham, NC, USA., Jang D; Department of Head and Neck Surgery and Communication Sciences, School of Medicine, Duke University, Durham, NC, USA., Goldstein BJ; Department of Head and Neck Surgery and Communication Sciences, School of Medicine, Duke University, Durham, NC, USA., Glass C; Department of Pathology, School of Medicine, Duke University, Durham, NC, USA., Heaton NS; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA., Hsu D; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, USA. Electronic address: shiaowen.hsu@duke.edu., Clevers H; Oncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 Utrecht, the Netherlands. Electronic address: h.clevers@hubrecht.eu., Shen X; Woo Center for Big Data and Precision Health, Pratt School of Engineering, Duke University, Durham, NC, USA; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA; Terasaki Institute, Los Angeles, CA, USA. Electronic address: xiling.shen@terasaki.org.
Publikováno v:
Stem cell reports [Stem Cell Reports] 2022 Sep 13; Vol. 17 (9), pp. 1959-1975. Date of Electronic Publication: 2022 Aug 18.
Autor:
van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Publikováno v:
The EMBO journal [EMBO J] 2022 May 16; Vol. 41 (10), pp. e109675. Date of Electronic Publication: 2022 Apr 11.
Autor:
van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kooiman BAP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Groenveld F; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Utrecht, The Netherlands., Ariese HCR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Korving J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Holstege F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Rheenen J; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Bos FL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Publikováno v:
Developmental dynamics : an official publication of the American Association of Anatomists [Dev Dyn] 2021 Nov; Vol. 250 (11), pp. 1568-1583. Date of Electronic Publication: 2021 May 06.
Autor:
van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Barrera Roman M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Martínez Mir C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Bos FL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Heukers R; QVQ Holding BV, Utrecht, the Netherlands., Chuva de Sousa Lopes SM; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, the Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Cancer Genomics Netherlands, Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2021 Oct; Vol. 39 (10), pp. 1239-1245. Date of Electronic Publication: 2021 Jun 03.
Autor:
Ponsioen B; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Post JB; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Buissant des Amorie JR; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Laskaris D; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., van Ineveld RL; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Kersten S; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Bertotti A; Laboratory of Translational Cancer Medicine, Candiolo Cancer Institute - FPO IRCCs, Candiolo, Torino, Italy.; Department of Oncology, University of Torino School of Medicine, Candiolo, Torino, Italy., Sassi F; Laboratory of Translational Cancer Medicine, Candiolo Cancer Institute - FPO IRCCs, Candiolo, Torino, Italy., Sipieter F; Molecular Signaling and Cell Death Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; Molecular Signaling and Cell Death Unit, Center for Inflammation Research (IRC), a VIB-UGent department, Ghent, Belgium.; Institut Jacques Monod, CNRS UMR 7592, Université Paris Diderot, Paris, France., Cappe B; Molecular Signaling and Cell Death Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; Molecular Signaling and Cell Death Unit, Center for Inflammation Research (IRC), a VIB-UGent department, Ghent, Belgium., Mertens S; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Verlaan-Klink I; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Boj SF; Foundation Hubrecht Organoid Technology (HUB), Utrecht, Netherlands., Vries RGJ; Foundation Hubrecht Organoid Technology (HUB), Utrecht, Netherlands., Rehmann H; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Vandenabeele P; Molecular Signaling and Cell Death Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; Molecular Signaling and Cell Death Unit, Center for Inflammation Research (IRC), a VIB-UGent department, Ghent, Belgium., Riquet FB; Molecular Signaling and Cell Death Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.; Molecular Signaling and Cell Death Unit, Center for Inflammation Research (IRC), a VIB-UGent department, Ghent, Belgium.; University of Lille, Villeneuve d'Ascq, France., Trusolino L; Laboratory of Translational Cancer Medicine, Candiolo Cancer Institute - FPO IRCCs, Candiolo, Torino, Italy.; Department of Oncology, University of Torino School of Medicine, Candiolo, Torino, Italy., Bos JL; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Snippert HJG; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. h.j.g.snippert@umcutrecht.nl.; Oncode Institute, Utrecht, Netherlands. h.j.g.snippert@umcutrecht.nl.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2021 Apr; Vol. 23 (4), pp. 377-390. Date of Electronic Publication: 2021 Apr 01.